The costs of asthma

At present, asthma represents a substantial burden on health care resources in all countries so far studied. The costs of asthma are largely due to uncontrolled disease, and are likely to rise as its prevalence and severity increase. Costs could be significantly reduced if disease control is improved. A large proportion of the total cost of illness is derived from treating the consequences of poor asthma control-direct costs, such as emergency room use and hospitalizations. Indirect costs, which include time off work or school and early retirement, are incurred when the disease is not fully controlled and becomes severe enough to have an effect on daily life. In addition, quality of life assessments show that asthma has a significant socioeconomic impact, not only on the patients themselves, but on the whole family. Underuse of prescribed therapy, which includes poor compliance, significantly contributes towards the poor control of asthma. The consequences of poor compliance in asthma include increased morbidity and sometimes mortality, and increased health care expenditure. To improve asthma management, international guidelines have been introduced which recommend an increase in the use of prophylactic therapy. The resulting improvements in the control of asthma will reduce the number of hospitalizations associated with asthma, and may ultimately produce a shift within direct costs, with subsequent reductions in indirect costs. In addition, costs may be reduced by improving therapeutic interventions and through effective patient education programmes. This paper reviews current literature on the costs of asthma to assess how effectively money is spent and, by estimating the proportion of the cost attributable to uncontrolled disease, will identify where financial savings might be made.

This article has been cited by other articles:

				P. Kenny, J. Hall, M. King, and E. Lancsar Sources of variation in the costs of health care for asthma patients in Australia J Health Serv Res Policy, July 1, 2009; 14(3): 133 - 140. [Abstract] [Full Text] [PDF]

				J. Bousquet, U. Wahn, E. O. Meltzer, H. Fox, S. Hedgecock, K. Thomas, and A. Fowler-Taylor Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases Eur. Respir. Rev., April 1, 2008; 17(107): 1 - 9. [Abstract] [Full Text] [PDF]

				F. Braido and G. W. Canonica Worldwide differences on the concept of control of asthma Therapeutic Advances in Respiratory Disease, February 1, 2008; 2(1): 3 - 5. [Abstract] [PDF]

				D. E. Shaw, M. A. Berry, M. Thomas, R. H. Green, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 231 - 237. [Abstract] [Full Text] [PDF]

				A. E. Williams, A. C. Lloyd, L. Watson, and K. F. Rabe Cost of scheduled and unscheduled asthma management in seven European Union countries Eur. Respir. Rev., June 1, 2006; 15(98): 4 - 9. [Abstract] [Full Text] [PDF]

				C. K. W. Lai, Y-Y. Kim, S-H. Kuo, M. Spencer, A. E. Williams, and on behalf of the Asthma Insights and Reality in As Cost of asthma in the Asia-Pacific region Eur. Respir. Rev., June 1, 2006; 15(98): 10 - 16. [Abstract] [Full Text] [PDF]

				D. Vervloet, A. E. Williams, A. Lloyd, and T. J. H. Clark Costs of managing asthma as defined by a derived Asthma Control TestTM score in seven European countries Eur. Respir. Rev., June 1, 2006; 15(98): 17 - 23. [Abstract] [Full Text] [PDF]

				C. Runge, J. Lecheler, M. Horn, J.-T. Tews, and M. Schaefer Outcomes of a Web-Based Patient Education Program for Asthmatic Children and Adolescents Chest, March 1, 2006; 129(3): 581 - 593. [Abstract] [Full Text] [PDF]

				Y.-L. Lee, T.-R. Hsiue, C.-H. Lee, H.-J. J. Su, and Y. Leon Guo Home exposures, parental atopy, and occurrence of asthma symptoms in adulthood in southern taiwan. Chest, February 1, 2006; 129(2): 300 - 308. [Abstract] [Full Text] [PDF]

				S. Mangiapane, M. Schulz, S. Muhlig, P. Ihle, I. Schubert, and H.-C. Waldmann Community Pharmacy-Based Pharmaceutical Care for Asthma Patients Ann. Pharmacother., November 1, 2005; 39(11): 1817 - 1822. [Abstract] [Full Text] [PDF]

				S. Stock, M. Redaelli, M. Luengen, G. Wendland, D. Civello, and K. W. Lauterbach Asthma: prevalence and cost of illness Eur. Respir. J., January 1, 2005; 25(1): 47 - 53. [Abstract] [Full Text] [PDF]

				L. Nathell Effects on sick leave of an inpatient rehabilitation programme for asthmatics in a randomized trial Scand J Public Health, January 1, 2005; 33(1): 57 - 64. [Abstract] [PDF]

				P. Ikaheimo, T. Tuuponen, S. Hartikainen, J. Kiuttu, and T. Klaukka Achievements and shortcomings of Finnish asthma care Scand J Public Health, August 1, 2004; 32(4): 310 - 316. [Abstract] [PDF]

				V. S. Kocevar, H. Bisgaard, L. Jonsson, E. Valovirta, F. Kristensen, D. D. Yin, and J. Thomas III Variations in Pediatric Asthma Hospitalization Rates and Costs Between and Within Nordic Countries Chest, May 1, 2004; 125(5): 1680 - 1684. [Abstract] [Full Text] [PDF]

				A.W.A. Kamps, R.J. Roorda, J.L.L. Kimpen, A.W. Overgoor-van de Groes, L.C.J.A.M. van Helsdingen-Peek, and P.L.P. Brand Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs Eur. Respir. J., February 1, 2004; 23(2): 304 - 309. [Abstract] [Full Text] [PDF]

				O. Vandenplas, K. Toren, and P.D. Blanc Health and socioeconomic impact of work-related asthma Eur. Respir. J., October 1, 2003; 22(4): 689 - 697. [Abstract] [Full Text] [PDF]

				R H Green, C E Brightling, I D Pavord, and A J Wardlaw Management of asthma in adults: current therapy and future directions Postgrad. Med. J., May 1, 2003; 79(931): 259 - 267. [Abstract] [Full Text] [PDF]

				N. Jakeways, T. McKeever, S.A. Lewis, S.T. Weiss, and J. Britton Relationship between FEV1 reduction and respiratory symptoms in the general population Eur. Respir. J., April 1, 2003; 21(4): 658 - 663. [Abstract] [Full Text] [PDF]

				B P A Thoonen, T R J Schermer, G van den Boom, J Molema, H Folgering, R P Akkermans, R Grol, C van Weel, and C P van Schayck Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial Thorax, January 1, 2003; 58(1): 30 - 36. [Abstract] [Full Text] [PDF]

				L. Irvine, I.K. Crombie, E.M. Alder, R.G. Neville, and R.A. Clark What predicts poor collection of medication among children with asthma? A case-control study Eur. Respir. J., December 1, 2002; 20(6): 1464 - 1469. [Abstract] [Full Text] [PDF]

				T. R. Schermer, B. P. Thoonen, G. van den Boom, R. P. Akkermans, R. P. Grol, H. T. Folgering, C. van Weel, and C. P. van Schayck Randomized Controlled Economic Evaluation of Asthma Self-Management in Primary Health Care Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1062 - 1072. [Abstract] [Full Text] [PDF]

				E. Van Ganse, L. Laforest, G. Pietri, J.P. Boissel, F. Gormand, R. Ben-Joseph, and P. Ernst Persistent asthma: disease control, resource utilisation and direct costs Eur. Respir. J., August 1, 2002; 20(2): 260 - 267. [Abstract] [Full Text] [PDF]

				E. Valovirta, V. Sazonov Kocevar, M. Kaila, M. Kajosaari, A. Koivikko, K. Korhonen, O. Linna, M. Makela, K. Remes, and R.H. Ben-Joseph Inpatient resource utilisation in younger (2-5 yrs) and older (6-14 yrs) asthmatic children in Finland Eur. Respir. J., August 1, 2002; 20(2): 397 - 402. [Abstract] [Full Text] [PDF]

				E. Yelin, L. Trupin, M. Cisternas, M. Eisner, P. Katz, and P. Blanc A national study of medical care expenditures for respiratory conditions Eur. Respir. J., March 1, 2002; 19(3): 414 - 421. [Abstract] [Full Text] [PDF]

				Y. Chen, R. Dales, M. Tang, and D. Krewski Obesity May Increase the Incidence of Asthma in Women but Not in Men: Longitudinal Observations from the Canadian National Population Health Surveys Am. J. Epidemiol., February 1, 2002; 155(3): 191 - 197. [Abstract] [Full Text] [PDF]

				H. Bisgaard, M. J. Price, C. Maden, and N. A. Olsen Cost-Effectiveness of Fluticasone Propionate Administered Via Metered-Dose Inhaler Plus BabyhalerTM Spacer in the Treatment of Asthma in Preschool-Aged Children Chest, December 1, 2001; 120(6): 1835 - 1842. [Abstract] [Full Text] [PDF]

				M. Soler, J. Matz, R. Townley, R. Buhl, J. O'Brien, H. Fox, J. Thirlwell, N. Gupta, and G. Della Cioppa The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Eur. Respir. J., August 1, 2001; 18(2): 254 - 261. [Abstract] [Full Text] [PDF]

				L Dow, L Fowler, L Phelps, K Waters, D Coggon, A L Kinmonth, and S T Holgate Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK Thorax, June 1, 2001; 56(6): 472 - 476. [Abstract] [Full Text]

				J.A. Cropper, T.L. Frank, P.I. Frank, M.L. Laybourn, and P.C. Hannaford Respiratory illness and healthcare utilization in children: the primary and secondary care interface Eur. Respir. J., May 1, 2001; 17(5): 892 - 897. [Abstract] [Full Text] [PDF]

				A. ten BRINKE, M. E. OUWERKERK, A. H. ZWINDERMAN, P. SPINHOVEN, and E. H. BEL Psychopathology in Patients with Severe Asthma Is Associated with Increased Health Care Utilization Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1093 - 1096. [Abstract] [Full Text]

				Y. Chen, R. Dales, and D. Krewski Asthma and the Risk of Hospitalization in Canada : The Role of Socioeconomic and Demographic Factors Chest, March 1, 2001; 119(3): 708 - 713. [Abstract] [Full Text] [PDF]

				F. Gallefoss and P.S. Bakke Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial Eur. Respir. J., February 1, 2001; 17(2): 206 - 213. [Abstract] [Full Text] [PDF]

				D. Sistek, J-M. Tschopp, C. Schindler, M. Brutsche, U. Ackermann-Liebrich, A-P. Perruchoud, P. Leuenberger, and SAPALDIA team Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study Eur. Respir. J., February 1, 2001; 17(2): 214 - 219. [Abstract] [Full Text] [PDF]

				J. D. LEUPPI, C. M. SALOME, C. R. JENKINS, S. D. ANDERSON, W. XUAN, G. B. MARKS, H. KOSKELA, J. D. BRANNAN, R. FREED, M. ANDERSSON, et al. Predictive Markers of Asthma Exacerbation during Stepwise Dose Reduction of Inhaled Corticosteroids Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 406 - 412. [Abstract] [Full Text]

				J Kolbe, W Fergusson, M Vamos, and J Garrett Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack Thorax, December 1, 2000; 55(12): 1007 - 1015. [Abstract] [Full Text]

				M. Neri and A. Spanevello Chronic bronchial asthma from challenge to treatment: epidemiology and social impact Thorax, October 1, 2000; 55(90002): 57S - 58. [Full Text]

				P. J. Barnes Anti-IgE Antibody Therapy for Asthma N. Engl. J. Med., December 23, 1999; 341(26): 2006 - 2008. [Full Text]

				P. D. BLANC, S. ELLBJÄR, C. JANSON, D. NORBÄCK, E. NORRMAN, P. PLASCHKE, and K. TORÉN Asthma-related Work Disability in Sweden . The Impact of Workplace Exposures Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2028 - 2033. [Abstract] [Full Text]

				J. C. C. M.i.`t VEEN, H. H. SMITS, P. S. HIEMSTRA, A. E. ZWINDERMAN, P. J. STERK, and E. H. BEL Lung Function and Sputum Characteristics of Patients with Severe Asthma During an Induced Exacerbation by Double-Blind Steroid Withdrawal Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 93 - 99. [Abstract] [Full Text]

				F. GALLEFOSS, P. S. BAKKE, and P. KJAERSGAARD Quality of Life Assessment after Patient Education in a Randomized Controlled Study on Asthma and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 812 - 817. [Abstract] [Full Text]

				G. Moscato, A. Dellabianca, L. Perfetti, B. Brame, E. Galdi, R. Niniano, and P. Paggiaro Occupational Asthma: A Longitudinal Study on the Clinical and Socioeconomic Outcome After Diagnosis Chest, January 1, 1999; 115(1): 249 - 256. [Abstract] [Full Text] [PDF]

				G. van den BOOM, C. P. van SCHAYCK, M. P. M. H. RUTTEN-van MOLKEN, P. R. S. TIRIMANNA, J. J. den OTTER, P. M. van GRUNSVEN, M. J. BUITENDIJK, C. L. A. van HERWAARDEN, and C. van WEEL Active Detection of Chronic Obstructive Pulmonary Disease and Asthma in the General Population . Results and Economic Consequences of the DIMCA Program Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1730 - 1738. [Abstract] [Full Text] [PDF]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]

				D. J. Evans, D. A. Taylor, O. Zetterstrom, K. F. Chung, B. J. O'Connor, and P. J. Barnes A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma N. Engl. J. Med., November 13, 1997; 337(20): 1412 - 1419. [Abstract] [Full Text] [PDF]